Cycles of depalmitoylation and repalmitoylation critically control the steady-state localization and function of various peripheral membrane proteins, such as Ras proto-oncogene products. Interference with acylation using small molecules is a strategy to modulate cellular localization—and thereby unregulated signaling—caused by palmitoylated Ras proteins. We present the knowledge-based development and characterization of a potent inhibitor of acyl protein thioesterase 1 (APT1), a bona fide depalmitoylating enzyme that is, so far, poorly characterized in cells. The inhibitor, palmostatin B, perturbs the cellular acylation cycle at the level of depalmitoylation and thereby causes a loss of the precise steady-state localization of palmitoylated Ras. As a consequence, palmostatin B induces partial phenotypic reversion in oncogenic HRasG12V-transformed fibroblasts. We identify APT1 as one of the thioesterases in the acylation cycle and show that this protein is a cellular target of the inhibitor.
- The on-off story of protein palmitoylation. Trends Cell Biol. 13, 32–42 (2003). &
- 2-Bromopalmitate and 2-(2-hydroxy-5-nitro- benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro . J. Lipid Res. 50, 233–242 (2009). et al.
- Palmitoylation-dependent protein sorting. J. Cell Biol. 176, 249–254 (2007). &
- An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307, 1746–1752 (2005). et al.
- The palmitoylation machinery is a generic sorting system for peripheral membrane proteins. Cell Published online 30 April 2010; doi:10.1016/j.cell.2010.04.007. et al.
- Use of analogs and inhibitors to study the functional significance of protein palmitoylation. Methods 40, 191–197 (2006).
- A cytoplasmic acyl-protein thioesterase that removes palmitate from G protein α subunits and p21RAS. J. Biol. Chem. 273, 15830–15837 (1998). &
- Depalmitoylation of endothelial nitric-oxide synthase by acyl- protein thioesterase 1 is potentiated by Ca2+-calmodulin. J. Biol. Chem. 274, 33148–33154 (1999). et al.
- Compound library development guided by protein structure similarity clustering and natural product structure. Proc. Natl. Acad. Sci. USA 101, 16721–16726 (2004). et al.
- Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics. Curr. Opin. Chem. Biol. 9, 232–239 (2005). , &
- Crystal structure of the human acyl protein thioesterase I from a single X-ray data set to 1.5 Å. Structure 8, 1137–1146 (2000). et al.
- Similarity in Chemical and Protein Space: Finding Novel Starting Points for Library Design (Thesis, Dortmund University, 2009). MPG E-Doc System (http://edoc.mpg.de/), ID:442195.0.
- The FSSP database of structurally aligned protein fold families. Nucleic Acids Res. 17, 3600–3609 (1994). &
- DaliLite workbench for protein structure comparison. Bioinformatics 16, 566–567 (2000). &
- Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor. J. Biol. Chem. 277, 2266–2274 (2002). et al.
- Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J. Antibiot. 40, 1081–1085 (1987). et al.
- The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. J. Biol. Chem. 266, 2021–2027 (1991). et al.
- β-Lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. Angew. Chem. Int. Ed. 47, 4600–4603 (2008). &
- β-lactone probes identify a papain-like peptide ligase in Arabidopsis thaliana . Nat. Chem. Biol. 4, 557–563 (2008). et al.
- Boron-mediated aldol reaction of carboxylic esters: complementary anti- and syn-selective asymmetric aldol reactions. J. Org. Chem. 67, 5250–5256 (2002). et al.
- Asymmetric aldol additions: use of titanium tetrachloride and (–)-sparteine for the soft enolization of N-acyl oxazolidinones, oxazolidinethiones, and thiazolidinethiones. J. Org. Chem. 66, 894–902 (2001). et al.
- Bioorganic synthesis of lipid-modified proteins for the study of signal transduction. Nature 403, 223–226 (2000). et al.
- Synthesis of functional Ras lipoproteins and fluorescent derivatives. J. Am. Chem. Soc. 123, 1023–1035 (2001). et al.
- 2-Bromopalmitoyl-CoA and 2-bromopalmitate: promiscuous inhibitors of membrane-bound enzymes. Biochim. Biophys. Acta 1125, 203–209 (1992). et al.
- Labeling and quantifying sites of protein palmitoylation. Biotechniques 36, 276–285 (2004). &
- In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays. Nat. Methods (in the press). et al.
- Lipidated peptides as tools for understanding the membrane interactions of lipid-modified proteins. in Peptide-Lipid Interactions, Current Topics in Membranes vol. 52 (ed. Simon, S.A. & McIntosh, T.J.) 372-397 (Academic, 2002).
- Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J. Biol. Chem. 275, 261–270 (2000). , &
- Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 4, 343–350 (2002). et al.
- Spatio-temporal segregation of Ras signals: one ship, three anchors, many harbors. Curr. Opin. Cell Biol. 18, 351–357 (2006). , &
- Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol. Cell. Biol. 26, 100–116 (2006). et al.
- The new sulindac derivative IND 12 reverses Ras-induced cell transformation. Cancer Res. 62, 1718–1723 (2002). et al.
- Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening. Angew. Chem. Int. Ed. 43, 450–454 (2004). et al.
- Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108, 2435–2447 (1989). et al.
- Loss of E-cadherin promotes metastasis via multipledownstream transcriptional pathways. Cancer Res. 68, 3645–3654 (2008). et al.
- Development and biological evaluation of acyl protein thioesterase 1 (APT1) inhibitors. Angew. Chem. Int. Ed. 44, 4975–4980 (2005). et al.
- Synthesis and evaluation of acyl protein thioesterase 1 (APT1) inhibitors. Chem. Eur. J. 12, 4121–4143 (2006). et al.
- Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5, 806–811 (1993).
- Targeting Ras signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11–22 (2003).
- Measurement of co-localisation of objects in dual-colour confocal images. J. Microsc. 169, 375–382 (1993). , &
- Supplementary Text and Figures (516K)
Supplementary Methods, Supplementary Results, Supplementary Figures 1–13, Supplementary Schemes 1–2 and Supplementary Tables 1–5